Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update Alert: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults
Devan Kansagara, Katherine Mackey, Kathryn Vela
Annals of Internal Medicine (2020) Vol. 173, Iss. 3, pp. W66-W66
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

First results of the “Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)”
Carolin E. M. Jakob, Stefan Borgmann, Fazılet Duygu, et al.
Infection (2020) Vol. 49, Iss. 1, pp. 63-73
Open Access | Times Cited: 75
Proliferation of Papers and Preprints During the Coronavirus Disease 2019 Pandemic: Progress or Problems With Peer Review?
Caitlyn Vlasschaert, Joel Michels Topf, Swapnil Hiremath
Advances in Chronic Kidney Disease (2020) Vol. 27, Iss. 5, pp. 418-426
Open Access | Times Cited: 71
Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney
Xiao Jiang, James Eales, David Scannali, et al.
European Heart Journal (2020) Vol. 41, Iss. 48, pp. 4580-4588
Open Access | Times Cited: 51
Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort study
Didier Collard, Nick S. Nurmohamed, Yannick Kaiser, et al.
BMJ Open (2021) Vol. 11, Iss. 2, pp. e045482-e045482
Open Access | Times Cited: 44
COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?
Tiziana Filardi, Susanna Morano
Journal of Endocrinological Investigation (2020) Vol. 43, Iss. 8, pp. 1053-1060
Open Access | Times Cited: 48
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor
Murat Öz, Dietrich E. Lorke, Nadine Kabbani
Pharmacology & Therapeutics (2020) Vol. 221, pp. 107750-107750
Open Access | Times Cited: 41
Past, present and future of living systematic review: a bibliometrics analysis
Qingyong Zheng, Jianguo Xu, Ya Gao, et al.
BMJ Global Health (2022) Vol. 7, Iss. 10, pp. e009378-e009378
Open Access | Times Cited: 20
Extension of the PRISMA 2020 statement for living systematic reviews (PRISMA-LSR): checklist and explanation
Elie A. Akl, Joanne Khabsa, Claire Iannizzi, et al.
BMJ (2024), pp. e079183-e079183
Open Access | Times Cited: 4
Obesity, vitamin D deficiency and old age a serious combination with respect to coronavirus disease-2019 severity and outcome
Hans K. Biesalski
Current Opinion in Clinical Nutrition & Metabolic Care (2020) Vol. 24, Iss. 1, pp. 18-24
Closed Access | Times Cited: 29
Association of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers with risk of mortality, severity or SARS-CoV-2 test positivity in COVID-19 patients: meta-analysis
Mohitosh Biswas, Most. Sumaiya Khatun Kali
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22
Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans
Catherine G. Derington, Jordana B. Cohen, April F. Mohanty, et al.
PLoS ONE (2021) Vol. 16, Iss. 4, pp. e0248080-e0248080
Open Access | Times Cited: 22
Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?
Mariele Montanari, Barbara Canonico, Evelyn Nordi, et al.
Advances in Biological Regulation (2021) Vol. 81, pp. 100820-100820
Open Access | Times Cited: 19
Navigating migraine care through the COVID-19 pandemic: an update
Heather Angus‐Leppan, Angelica E. Guiloff, Karen Benson, et al.
Journal of Neurology (2021) Vol. 268, Iss. 11, pp. 4388-4395
Open Access | Times Cited: 17
Exploring Drugs and Vaccines Associated with Altered Risks and Severity of COVID-19: A UK Biobank Cohort Study of All ATC Level-4 Drug Categories Reveals Repositioning Opportunities
Yong Xiang, Kenneth Chi-Yin Wong, Hon‐Cheong So
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1514-1514
Open Access | Times Cited: 17
Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils
Lauren A. Baldassarre, Eric H. Yang, Richard K. Cheng, et al.
JNCI Journal of the National Cancer Institute (2020) Vol. 113, Iss. 5, pp. 513-522
Open Access | Times Cited: 15
COVID-19 and Cardiovascular Disease: Mechanisms and Implications
Irena Mitevska
IntechOpen eBooks (2021)
Open Access | Times Cited: 12
Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial
Carinna Hockham, Sradha Kotwal, Arlen Wilcox, et al.
Trials (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Renin-angiotensin-aldosterone system inhibitors and COVID-19 infection or hospitalization: a cohort study
Sascha Dublin, Rod Walker, James S. Floyd, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 9
3219 hospitalised patients with COVID-19 in Southeast Michigan: a retrospective case cohort study
Elie Mulhem, Andrew Oleszkowicz, David J. Lick
BMJ Open (2021) Vol. 11, Iss. 4, pp. e042042-e042042
Open Access | Times Cited: 8
Meta-analysis of the association between angiotensin pathway inhibitors and COVID-19 severity and mortality
Malindu E. Fernando, Aaron Drovandi, Jonathan Golledge
Systematic Reviews (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Mortality, Severity, and Hospital Admission among COVID-19 Patients with ACEI/ARB Use: A Meta-Analysis Stratifying Countries Based on Response to the First Wave of the Pandemic
Ahmad Alamer, Abdulaziz Almulhim, Ahmed Alrashed, et al.
Healthcare (2021) Vol. 9, Iss. 2, pp. 127-127
Open Access | Times Cited: 7
Association Between ACEIs or ARBs Use and Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-analysis
Carlos Díaz-Arocutipa, Jose Saucedo‐Chinchay, Adrían V. Hernández
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 6
Need for innovative and timely synthesis of evidence during Covid-19 outbreak
Giulio Francesco Romiti, Bernadette Corica, Roberto Cangemi, et al.
European Journal of Internal Medicine (2020) Vol. 77, pp. 165-166
Open Access | Times Cited: 6
COVID-19: frequently asked questions to the cardiologist
Andreas A. Kammerlander, Julia Mascherbauer
Wiener klinische Wochenschrift (2020) Vol. 132, Iss. 21-22, pp. 690-692
Open Access | Times Cited: 5
Exploring drugs and vaccines associated with altered risks and severity of COVID-19: a UK Biobank cohort study of all ATC level-4 drug categories
Yong Xiang, Kenneth Chi-Yin Wong, SO Hon-Cheong
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top